Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hong-wen Fei M.D."'
Autor:
Alphonse G. Taghian, Hong-wen Fei M.D., Elkan F. Halpern, Marielle Scherrer-Crosbie, Lanqi Hua, Laura Salama, Timothy C. Tan, Kai-Hung Cheng, Shannon M. MacDonald, Xin Zeng, Mohammed T. Ali
Publikováno v:
Echocardiography. 33:519-526
Aim The combination of anthracyclines (AC) and trastuzumab (TRZ) is highly effective in patients with aggressive HER-2 + breast cancer, but has a significant risk of cardiotoxicity (CT). Trastuzumab-induced CT may be reversible. The aim of this study
Autor:
Marielle Scherrer-Crosbie, Elkan F. Halpern, Hong-wen Fei M.D., Irene Kuter, Timothy C. Tan, Arthur E. Weyman, Tomas G. Neilan, Lin Wang, Michael H. Picard, Ephraim P. Hochberg, Jeremy S. Abramson, Sanjeev A. Francis
Publikováno v:
The American Journal of Cardiology. 116:442-446
Anthracyclines are an important component of cancer treatments; however, their use is limited by the occurrence of cardiotoxicity. There are limited data on the occurrence of heart failure and the value of baseline and follow-up measurements of left
Autor:
Elkan F. Halpern, Lin Wang, Evin Yucel, Mohammed Ali, Marielle Scherrer-Crosbie, Hong-wen Fei M.D., Souhila Bouras
Publikováno v:
Journal of the American Society of Echocardiography. 29:522-527.e3
Anthracycline-induced symptomatic heart failure is often irreversible, underlining the usefulness of pretreatment risk assessment. Global longitudinal strain (GLS) before or after chemotherapy is associated with a later decrease in left ventricular e